Source: Getty Images Six months after receiving low-intensity extracorporeal shock wave therapy nearly 52% of men reported having satisfactory sexual intercourse, a study found. Low-intensity ...

Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Boctor, the President and Chief Commercial Officer of ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

Men with primary organic erectile dysfunction (ED) are less likely than those with primary psychogenic ED to adhere to treatment with PDE5 inhibitors. Men with primary organic erectile dysfunction (ED ...

Add Yahoo as a preferred source to see more of our stories on Google. Erectile dysfunction can cause a “self-perpetuating cycle of anxiety and performance pressure,” says one expert. (Photo ...

Erectile dysfunction (ED) is a common condition affecting millions of men worldwide. While traditional treatments, such as medications and surgical methods, offer temporary relief, new advancements in ...

Erectile dysfunction is a common sexual abnormality in men. The condition is characterized by the inability to get or keep an erection during sexual activity. New regenerative therapies have shown ...

New ED Formulation Puts Focus on Men's Sexual Health as Part of Overall Wellness TAMPA, Fla., Jan. 28, 2026 /PRNewswire/ -- BoomRx, the fastest-growing national pharmaceutical technology platform that ...

Kranus Health GmbH has raised $6.5 million in series A funding to ramp commercialization of its digital therapy for treating erectile dysfunction (ED). Eleven European investors participated in this ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) failed to improve erectile dysfunction (ED) versus a sham procedure in men who had undergone radical prostatectomy, a small randomized trial ...